Therefore, we used the clinical data and expression profile of TCGA-LUAD to analyze the association between the expression of NCAPG2 and EIF2S3, the clinical stage, and lymph node metastasis. Here, NCAPG2 is linked to metastatic malignant neoplasm in the lymph nodes.